Notice of Certification of the Paxil Class Action
05 Dicembre 2015 - 2:00PM
PR Newswire (Canada)
WATERLOO, ON, Dec. 5, 2015 /CNW/ - Crawford Class Action
Services reports that the Supreme Court of British Columbia has required that notice of a
certified class action against GlaxoSmithKline Inc.
("GlaxoSmithKline") be provided and has confirmed that an opt-in
and opt-out deadline of April 4, 2016
applies for individuals wishing to participate. The class action
was commenced in British Columbia
in 2008 against GlaxoSmithKline as the manufacturer of the
antidepressant called Paxil. The lawsuit alleged that ingestion of
Paxil during pregnancy caused cardiovascular birth defects in
newborns. The class action was certified on behalf of a National
Class across Canada.
SOURCE Crawford & Company (Canada) Inc.
Copyright 2015 Canada NewsWire
Grafico Azioni Crawford (NYSE:CRD.A)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Crawford (NYSE:CRD.A)
Storico
Da Feb 2024 a Feb 2025
Notizie in Tempo Reale relative a Crawford and Company (Borsa di New York (NYSE)): 0 articoli recenti
Più Crawford & Company (Canada) Inc. Articoli Notizie
